✦ LIBER ✦

Vinorelbine (VNR) plus best supportive care (BSC) vs. BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (PTS). Results of a phase III randomized trial

✍ Scribed by Gridelli, C; Ianniello, GP; Maiorino, L; Brancaccio, L; Cigolari, S; Bilancia, D; Aiello, R; Zuccarino, L; Pedicini, T; Zonato, S; Pappagallo, GL; Monfardini, S; Rossi, A; Gallo, C; Perrone, F

Book ID: 118575464
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 229 KB
Volume: 21
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(98)90065-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxotere® (TXT) versus best supportive c

Taxotere® (TXT) versus best supportive care (BSC) in chemonaive patients with unresectable non-small cell lung cancer (NSCLC): Final results of the phase iii study

✍ K. Roszkowski 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Pr4 ISEL: A Phase III survival study com

Pr4 ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small-cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens

✍ Thatcher, N.; Chang, A.; Parikh, P.; Pemberton, K.; Archer, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A prospective randomized trial of Taxote

A prospective randomized trial of Taxotere versus best supportive care (BSC) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: Survival update

✍ Shepherd, F; Dancey, J; Ramlau, R; Mattson, K; Gralla, R; Kim, Y; Berille, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

A multicenter, randomized, phase III stu

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

✍ Roszkowski, Kazimierz; Pluzanska, Anna; Krzakowski, Maciej; Smith, Alexander Pet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Preliminary results of a phase II random

Preliminary results of a phase II randomized trial of docetaxel vs vinorelbine as second-line treatment in previously cisplatin-treated advanced non-small cell lung cancer (NSCLC)

✍ Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

O-092 Randomized phase III study of doce

O-092 Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

✍ Tamura, K.; Kudoh, S.; Negoro, S.; Nakagawa, K.; Takada, M.; Katakami, N.; Matsu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB